Breaking News

Yesterday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
On The Fly	Fly Intel: After-Hours Movers » 18:59 03/01/21 03/01 18:59 03/01/21 18:59 INO Inovio $11.64 / +0.52 (+4.68%) , ASLN Aslan Pharmaceuticals $5.22 / +0.82 (+18.64%) , TTEC TTEC Holdings $88.80 / +4.49 (+5.33%) , ZM Zoom Video $409.67 / +35.805 (+9.58%) , HLIO Helios Technologies $67.14 / +1.295 (+1.97%) , AMRC Ameresco $60.46 / +3.18 (+5.55%) , TMDX TransMedics $36.30 / +0.33 (+0.92%) , MREO Mereo BioPharma $3.96 / +0.07 (+1.80%) , ROKU Roku $420.23 / +25.095 (+6.35%) , NLSN Nielsen $23.15 / +0.73 (+3.26%) , FGEN FibroGen $50.35 / +0.38 (+0.76%) , AI C3.ai $120.78 / +8.41 (+7.48%) , INSG Inseego $15.00 / +0.35 (+2.39%) , LMND Lemonade $132.23 / +6.5 (+5.17%) , MORF Morphic $84.57 / +48.64 (+135.37%) , SCPL SciPlay $19.28 / +1.07 (+5.88%) , NIO NIO $49.79 / +3.08 (+6.59%) , SWCH Switch $17.69 / +0.33 (+1.90%) , NVAX Novavax $239.73 / +8.52 (+3.68%) , SRPT Sarepta $86.94 / -0.07 (-0.08%) , SILK Silk Road Medical $55.35 / +0.53 (+0.97%) , OSUR OraSure $11.08 / +0.42 (+3.94%) , APPF AppFolio $160.72 / -4.985 (-3.01%) , SGMS Scientific Games $50.79 / +3.84 (+8.18%) , MELI MercadoLibre $1,715.90 / +80.81 (+4.94%) , RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) , COHU Cohu $46.01 / +2.46 (+5.65%) , BYND Beyond Meat $147.09 / +1.7 (+1.17%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZM TTEC TMDX SWCH SRPT SILK SGMS SCPL ROKU RDHL OSUR NVAX NLSN NIO MREO MORF MELI LMND INSG INO HLIO FGEN COHU BYND ASLN APPF AMRC AI ZM Zoom Video $409.67 / +35.805 (+9.58%) 03/01/21 Zoom Video jumps 8% to $444.10 after Q4 results, FY22 guidance beat estimates 03/01/21 Lumen announces launch of Zoom Phone 02/03/21 Zoom Video announces availability of Zoom Rooms innovations 01/26/21 User reports indicate Zoom Video experiencing issues, says DownDetector TTEC TTEC Holdings $88.80 / +4.49 (+5.33%) 03/01/21 TTEC Holdings raises semi-annual dividend by 7.5% to 43c per share 01/21/21 TTEC Holdings partners with Schwan's Home Delivery 12/03/20 TTEC Holdings declares special, one-time cash dividend of $2.14 per share 09/28/20 TTEC Holdings increases semi-annual cash dividend to 40c per share TMDX TransMedics $36.30 / +0.33 (+0.92%) 03/01/21 TransMedics announces scheduling of OCS Heart FDA AdCom meeting 09/28/20 FDA postpones advisory committee meeting to review TransMedics OCS Heart SWCH Switch $17.69 / +0.33 (+1.90%) 03/01/21 Switch drops about 7% to $16.51 after reporting mixed Q4 results 09/16/20 Switch appoints Angela Archon to Board of Directors, effective November 4 SRPT Sarepta $86.94 / -0.07 (-0.08%) 02/25/21 Sarepta rallies 2% to $86.15 after winning FDA approval for DMD treatment 02/25/21 Sarepta announces FDA approval of Amondys 45 02/08/21 Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs 01/13/21 Sarepta, Genevant announce collaboration for gene editing therapeutics SILK Silk Road Medical $55.35 / +0.53 (+0.97%) 02/25/21 Silk Road Medical publishes study on TCAR availability and MACE 02/04/21 Silk Road Medical 'isolated the root cause' related to stent recall 01/25/21 Silk Road Medical voluntarily recalling additional lots of Enroute system 01/13/21 Silk Road Medical reports voluntarily recall of ENROUTE SDS units SGMS Scientific Games $50.79 / +3.84 (+8.18%) 03/01/21 Scientific Games drops 5% to $48.00 after reporting Q4 results 03/01/21 International Game, Scientific Games sign cross-licensing agreement 12/10/20 Scientific Games to supply lottery games for SISAL in Morocco 12/01/20 Scientific Games partners with Genius Sports Group SCPL SciPlay $19.28 / +1.07 (+5.88%) 09/23/20 SciPlay appoints Danny Moy as Chief Strategy Officer ROKU Roku $420.23 / +25.095 (+6.35%) 03/01/21 Roku to acquire Nielsen's video advertising business 02/18/21 Roku CEO says FY21 revenue growth to fall below levels of Q1 and Q2 02/18/21 Roku reports Q4 Active accounts 51.2M vs. 36.9M last year 01/21/21 Cinedigm launches All3Media's streaming channel SO... REAL App on Roku RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 02/23/21 RedHill Biopharma to expand opaganib global Phase 2/3 COVID-19 study 01/29/21 RedHill Biopharma announces independent DSMB recommendation for opaganib 01/06/21 RedHill Biopharma's RHB-204 granted FDA Fast Track designation for NTM disease 12/31/20 RedHill Biopharma announces safety, efficacy data from Phase 2 COVID-19 study OSUR OraSure $11.08 / +0.42 (+3.94%) 01/29/21 OraSure's OM-505 saliva collection kit included in EUA granted to Ambry 01/28/21 OraSure's saliva collection device authorized by Health Canada for COVID-19 test 01/26/21 Chronomics selects OraSure's OMNIgene ORAL salive collection kit 01/21/21 OraSure's saliva collection kit Included in FDA authorization for exome platform NVAX Novavax $239.73 / +8.52 (+3.68%) 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 Novavax completes enrollment of PREVENT-19 Phase 3 trial NLSN Nielsen $23.15 / +0.73 (+3.26%) 02/25/21 Twitter exploring 'super follows,' users able to subscribe for exclusive content 02/16/21 Elliott buys Evergy, exits eBay in Q4 01/12/21 Nielsen begins tracking premium theatrical films distributed via streaming NIO NIO $49.79 / +3.08 (+6.59%) 02/01/21 NIO delivers 7,225 vehicles in January, up 352.1% 01/10/21 Fly Intel: Top five weekend stock stories 01/10/21 Nio partners with Nvidia to develop new generation of automated driving EV 01/03/21 NIO Inc. reports 7,007 vehicle deliveries in December 2020 MREO Mereo BioPharma $3.96 / +0.07 (+1.80%) 03/01/21 Point72 Asset Management reports 6.4% passive stake in Mereo BioPharma 12/17/20 Ultragenyx, Mereo BioPharma announce setrusumab license agreement 12/15/20 Mereo BioPharma provides update on continued listing of ADSs on Nasdaq 11/23/20 Mereo BioPharma appoints Suba Krishnan as SVP, clinical development MORF Morphic $84.57 / +48.64 (+135.37%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen MELI MercadoLibre $1,715.90 / +80.81 (+4.94%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 01/07/21 MercadoLibre announces repurchase of $440M convertible senior notes 11/24/20 Amazon Web Services selected by MercadoLibre as primary cloud provider LMND Lemonade $132.23 / +6.5 (+5.17%) 01/21/21 Lemonade director sells 65.5K shares of common stock 01/14/21 Lemonade falls -4.9% 01/12/21 Lemonade falls -6.0% 12/31/20 Lemonade reports over 1M active customers at end of 2020 INSG Inseego $15.00 / +0.35 (+2.39%) 02/24/21 Inseego to sell Ctrack South Africa operations for $36.2M INO Inovio $11.64 / +0.52 (+4.68%) 03/01/21 Inovio reports REVEAL 1 trial met primary, secondary endpoints 02/24/21 Qiagen, Inovio expand collaboration to develop NGS companion diagnostic 02/23/21 Inovio doses first patient in Phase 1B clinical trial for INO-4500 01/06/21 Inovio reports positive efficacy results from Phase 2 trial of VGX-3100 HLIO Helios Technologies $67.14 / +1.295 (+1.97%) 01/21/21 Helios Technologies to acquire BJN Technologies, terms undisclosed 10/12/20 Helios Technologies to acquire Balboa Water Group for $218.5M FGEN FibroGen $50.35 / +0.38 (+0.76%) 03/01/21 FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA 12/22/20 FibroGen doses first patient in ZEPHYRUS-2 Phase 3 study of pamrevlumab 12/19/20 AstraZeneca updates on U.S. regulatory review of roxadustat 12/18/20 FibroGen says FDA extends review period for roxadustat NDA COHU Cohu $46.01 / +2.46 (+5.65%) 12/07/20 Cohu CEO Luis Muller sells over $1M in company shares BYND Beyond Meat $147.09 / +1.7 (+1.17%) 02/25/21 Beyond Meat says currently in 'solid liquidity position' 02/25/21 Beyond Meat says proceeding with 'aggressive investment agenda' in 2021 02/25/21 Beyond Meat says seeing 'great growth' in household penetration 02/25/21 Beyond Meat says 'not prepared to elaborate' on new partnerships ASLN Aslan Pharmaceuticals $5.22 / +0.82 (+18.64%) 03/01/21 Aslan Pharmaceuticals reports 'positive' results from study of ASLAN004 02/18/21 Aslan Pharmaceuticals appoints Neil Graham to board of directors 01/26/21 Aslan Pharma's ASLAN003 shows potential for best-in-class DHODH inhibitor 10/22/20 Aslan Pharmaceuticals initiates third dose cohort of ASLAN004 APPF AppFolio $160.72 / -4.985 (-3.01%) 09/08/20 AppFolio sells MyCase to Apax Partners fund for $193M AMRC Ameresco $60.46 / +3.18 (+5.55%) 02/17/21 Ameresco in ESA pact with Nyack Public School District for phase ll renovations 02/05/21 Ameresco partners with Navy for $173M energy project at Norfolk Naval Shipyard 02/02/21 Ameresco, Wells Fargo announce collaboration to develop solar generation assets 11/25/20 Ameresco CEO sells 46.3K shares of common stock AI C3.ai $120.78 / +8.41 (+7.48%) 02/25/21 C3.ai awarded omnibus U.S. patent for end-to-end enterprise AI platform 02/01/21 Shell, C3, Baker Hughes, Microsoft launch Open AI Energy Initiative 12/31/20 C3.ai falls -5.9% 12/30/20 C3.ai rises 5.6% INO ASLN TTEC ZM HLIO AMRC TMDX MREO ROKU NLSN FGEN AI INSG LMND MORF SCPL NIO SWCH NVAX SRPT SILK OSUR APPF SGMS MELI RDHL COHU BYND INO Inovio $11.64 / +0.52 (+4.68%) 02/11/21 Oppenheimer Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target 02/11/21 Oppenheimer Inovio initiated with an Outperform at Oppenheimer 02/09/21 Maxim Heat data puts cancer vaccine discussion 'back on the table,' says Maxim 01/08/21 Benchmark Inovio price target lowered to $15 from $25 at Benchmark ASLN Aslan Pharmaceuticals $5.22 / +0.82 (+18.64%) 03/01/21 Piper Sandler Piper boosts Aslan target to $10 after positive atopic dematitis data 04/13/20 Piper Sandler Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler 03/18/20 Piper Sandler Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler TTEC TTEC Holdings $88.80 / +4.49 (+5.33%) 12/17/20 Canaccord TTEC Holdings price target raised to $90 from $77 at Canaccord 10/15/20 Canaccord TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy 10/15/20 Canaccord TTEC Holdings initiated with a Buy at Canaccord 08/10/20 Fly Intel: Top five analyst downgrades ZM Zoom Video $409.67 / +35.805 (+9.58%) 01/26/21 MKM Partners Fiverr downgraded to Sell from Neutral at MKM Partners 01/13/21 Stifel Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity 01/13/21 Morgan Stanley Investors have turned too negative on Zoom's persistence, says Morgan Stanley 12/24/20 DA Davidson DA Davidson likes Zoom push into email, says buy on recent selloff HLIO Helios Technologies $67.14 / +1.295 (+1.97%) 10/12/20 Baird Helios Technologies upgraded to Outperform from Neutral at Baird 05/29/20 Morgan Stanley Morgan Stanley upgrades Helios to Equal Weight following underperformance 05/29/20 Morgan Stanley Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley 03/27/20 Truist Helios Technologies price target lowered to $36 from $45 at SunTrust AMRC Ameresco $60.46 / +3.18 (+5.55%) 02/09/21 B. Riley Securities Ameresco price target raised to $72 from $50 at B. Riley Securities 01/26/21 Craig-Hallum Ameresco price target raised to $75 from $50 at Craig-Hallum 11/03/20 Craig-Hallum Ameresco price target raised to $50 from $38 at Craig-Hallum 11/03/20 B. Riley Securities Ameresco price target raised to $50 from $48 at B. Riley Securities TMDX TransMedics $36.30 / +0.33 (+0.92%) 02/24/21 Cowen TransMedics price target raised to $44 from $20 at Cowen 10/08/20 Fly Intel: Top five analyst downgrades 10/08/20 JPMorgan TransMedics downgraded to Neutral on 'missed' execution at JPMorgan 10/08/20 JPMorgan TransMedics downgraded to Neutral from Overweight at JPMorgan MREO Mereo BioPharma $3.96 / +0.07 (+1.80%) ROKU Roku $420.23 / +25.095 (+6.35%) 02/22/21 Needham Roku price target raised to $550 from $400 at Needham 02/19/21 Truist Roku price target raised to $480 from $390 at Truist 02/19/21 JPMorgan Roku price target raised to $525 from $475 at JPMorgan 02/19/21 Oppenheimer Roku price target raised to $500 from $260 at Oppenheimer NLSN Nielsen $23.15 / +0.73 (+3.26%) 03/01/21 Truist Nielsen price target raised to $26 from $20 at Truist 01/28/21 Citi Nielsen price target raised to $27 from $22 at Citi 11/03/20 Deutsche Bank Nielsen price target lowered to $18 from $22 at Deutsche Bank 08/25/20 Truist Nielsen price target lowered to $20 from $23 at Truist FGEN FibroGen $50.35 / +0.38 (+0.76%) 02/01/21 H.C. Wainwright FibroGen initiated with a Buy at H.C. Wainwright 12/21/20 Mizuho FibroGen should be bought on PDUFA extension weakness, says Mizuho 10/26/20 Raymond James FibroGen initiated with an Underperform at Raymond James 10/26/20 Raymond James FibroGen initiated with an Underperform at Raymond James AI C3.ai $120.78 / +8.41 (+7.48%) 01/04/21 KeyBanc C3.ai initiated with a Sector Weight at KeyBanc 01/04/21 Wedbush Wedbush bullish on C3.ai, initiates with an Outperform 01/04/21 Canaccord C3.ai initiated with a Hold at Canaccord 01/04/21 Morgan Stanley C3.ai initiated with an Underweight at Morgan Stanley INSG Inseego $15.00 / +0.35 (+2.39%) 02/17/21 Cowen Inseego price target raised to $20 from $17 at Cowen 09/04/20 Stifel Inseego 5G opportunity highlighted in meetings with management, says Stifel 08/06/20 Fly Intel: Top five analyst downgrades 08/06/20 Lake Street Inseego price target raised to $17 from $13 at Lake Street LMND Lemonade $132.23 / +6.5 (+5.17%) 01/21/21 Piper Sandler Lemonade price target raised to $163 from $105 at Piper Sandler 11/23/20 Morgan Stanley Root initiated with an Equal Weight at Morgan Stanley 11/12/20 Piper Sandler Lemonade price target raised to $71 from $63 at Piper Sandler 11/02/20 Piper Sandler Lemonade initiated with an Overweight at Piper Sandler MORF Morphic $84.57 / +48.64 (+135.37%) 03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital SCPL SciPlay $19.28 / +1.07 (+5.88%) 02/18/21 Deutsche Bank SciPlay price target raised to $23 from $20 at Deutsche Bank 02/17/21 BofA SciPlay double-downgraded to Underperform from Buy at BofA 12/22/20 Morgan Stanley SciPlay price target raised to $16 from $15 at Morgan Stanley 12/16/20 JPMorgan SciPlay downgraded to Neutral on tough comps at JPMorgan NIO NIO $49.79 / +3.08 (+6.59%) 02/26/21 HSBC NIO price target raised to $54 from $44.70 at HSBC 02/09/21 Deutsche Bank NIO job post shows ambitions to enter U.S. market, says Deutsche Bank 01/28/21 Morgan Stanley NIO price target raised to $80 from $33 at Morgan Stanley 01/22/21 Fly Intel: Top five analyst initiations SWCH Switch $17.69 / +0.33 (+1.90%) 02/02/21 Truist sees Switch positioned for long-term growth, starts at Buy 02/02/21 Truist Switch initiated with a Buy at Truist 01/13/21 Jefferies Switch upgraded to Buy on earnings growth inflection at Jefferies 01/13/21 Jefferies Switch upgraded to Buy from Hold at Jefferies NVAX Novavax $239.73 / +8.52 (+3.68%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/22/21 Cantor Fitzgerald Cantor says PREVENT-19 gives Novavax potential for differentiated analyses 02/22/21 B. Riley Securities B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up 02/18/21 B. Riley Securities Novavax price target raised to $397 from $334 at B. Riley Securities SRPT Sarepta $86.94 / -0.07 (-0.08%) 02/26/21 Mizuho Sarepta price target raised to $160 from $158 at Mizuho 02/25/21 Piper Sandler Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label' 02/09/21 Morgan Stanley Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley 01/12/21 Citi Sarepta downgraded to Neutral from Buy at Citi SILK Silk Road Medical $55.35 / +0.53 (+0.97%) 02/04/21 Piper Sandler Silk Road recall update 'should be received positively,' says Piper Sandler 01/25/21 Piper Sandler Silk Road Medical recall primarily manufacturing related, says Piper Sandler 01/13/21 Piper Sandler Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall 11/11/20 Piper Sandler Silk Road Medical price target raised to $58 from $54 at Piper Sandler OSUR OraSure $11.08 / +0.42 (+3.94%) 12/22/20 Lake Street Lake Street says OraSure test news disappointing, not due to fundamental issues 08/21/20 Fly Intel: Top five analyst initiations 08/21/20 Evercore ISI OraSure initiated with an Outperform at Evercore ISI 08/21/20 Evercore ISI OraSure initiated with an Outperform at Evercore ISI APPF AppFolio $160.72 / -4.985 (-3.01%) 02/25/21 DA Davidson AppFolio price target raised to $126 from $110 at DA Davidson 01/25/21 Stephens AppFolio initiated with an Underweight at Stephens 01/25/21 Stephens AppFolio initiated with an Underweight at Stephens 10/26/20 Keefe Bruyette AppFolio initiated with a Market Perform at Keefe Bruyette SGMS Scientific Games $50.79 / +3.84 (+8.18%) 02/09/21 Craig-Hallum Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum 01/19/21 Jefferies Scientific Games price target raised to $55 from $50 at Jefferies 01/14/21 Truist Scientific Games price target raised to $60 from $45 at Truist 01/14/21 Craig-Hallum Dec. NJ gaming data caps off year of significant growth, says Craig-Hallum MELI MercadoLibre $1,715.90 / +80.81 (+4.94%) 03/01/21 Credit Suisse MercadoLibre price target raised to $1,925 from $1,555 at Credit Suisse 02/11/21 Fly Intel: Top five analyst initiations 02/11/21 Scotiabank Scotiabank starts MercadoLibre at neutral, awaits better entry point 02/11/21 Scotiabank MercadoLibre initiated with a Sector Perform at Scotiabank RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 11/12/20 Roth Capital RedHill Biopharma price target lowered to $12 from $16 at Roth Capital 09/11/20 BTIG RedHill Biopharma initiated with a Buy at BTIG 08/14/20 Roth Capital Roth Capital maintains Buy on RedHill after 'noisy' quarter 07/07/20 SMBC Nikko RedHill Biopharma initiated with an Outperform at SMBC Nikko COHU Cohu $46.01 / +2.46 (+5.65%) 02/12/21 Craig-Hallum Cohu price target raised to $73 from $45 at Craig-Hallum 02/12/21 B. Riley Securities Cohu price target raised to $72 from $60 at B. Riley Securities 02/10/21 B. Riley Securities B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion 01/25/21 B. Riley Securities Cohu price target raised to $60 from $46 at B. Riley Securities BYND Beyond Meat $147.09 / +1.7 (+1.17%) 03/01/21 DA Davidson Beyond Meat price target raised to $145 from $133 at DA Davidson 02/26/21 Piper Sandler Beyond Meat relationship with McDonald's not much changed, says Piper Sandler 02/26/21 UBS Beyond Meat price target raised to $130 from $107 at UBS 02/26/21 Goldman Sachs Beyond Meat price target raised to $112 from $105 at Goldman Sachs ZM TTEC TMDX SWCH SRPT SILK SGMS SCPL ROKU RDHL OSUR NVAX NLSN NIO MREO MORF MELI LMND INSG INO HLIO FGEN COHU BYND ASLN APPF AMRC AI ZM Zoom Video $409.67 / +35.805 (+9.58%) 03/01/21 Zoom Video sees FY22 EPS $3.59-$3.65, consensus $2.96 03/01/21 Zoom Video sees Q1 EPS 95c-97c, consensus 72c 03/01/21 Zoom Video reports Q4 EPS $1.22, consensus 79c 03/01/21 Notable companies reporting after market close TTEC TTEC Holdings $88.80 / +4.49 (+5.33%) 03/01/21 TTEC Holdings sees FY21 EPS $4.06-$4.25, consensus $2.96 03/01/21 TTEC Holdings reports Q4 EPS $1.22, consensus 71c 11/04/20 TTEC Holdings raises FY20 EPS view to $2.92-$3.02 from $2.37-$2.43 11/04/20 TTEC Holdings reports Q3 adjusted EPS 90c, consensus 54c TMDX TransMedics $36.30 / +0.33 (+0.92%) 11/04/20 TransMedics reports Q3 EPS (19c), consensus (32c). SWCH Switch $17.69 / +0.33 (+1.90%) 03/01/21 Switch sees FY21 revenue $540M-$555M, consensus $588.3M 03/01/21 Switch reports Q4 adjusted EPS 6c, consensus 5c 11/05/20 Switch sees FY20 revenue $510M-$518M, consensus $516.47M 11/05/20 Switch reports Q3 EPS 5c, consensus 4c SRPT Sarepta $86.94 / -0.07 (-0.08%) 03/01/21 Sarepta reports Q4 EPS ($1.84), consensus ($1.77) 03/01/21 Sarepta reports Q4 EPS ($1.84), consensus ($1.77) 11/05/20 Sarepta reports Q3 EPS ($2.50), consensus ($1.71) SILK Silk Road Medical $55.35 / +0.53 (+0.97%) 03/01/21 Silk Road Medical sees FY21 revenue $102M-$108M, consensus $111.52M 03/01/21 Silk Road Medical reports Q4 EPS (49c), consensus (28c) 11/10/20 Silk Road Medical reports Q3 EPS (31c), consensus (28c) SGMS Scientific Games $50.79 / +3.84 (+8.18%) 03/01/21 Scientific Games reports Q4 EPS (95c), consensus (47c) 11/04/20 Scientific Games reports Q3 EPS ($1.23), consensus (77c) 11/04/20 Scientific Games reports Q3 EPS ($1.23), consensus (77c) 11/04/20 Notable companies reporting after market close SCPL SciPlay $19.28 / +1.07 (+5.88%) 03/01/21 SciPlay reports Q4 EPS 18c, consensus 26c 11/04/20 SciPlay reports Q3 EPS 23c, consensus 25c ROKU Roku $420.23 / +25.095 (+6.35%) 02/18/21 Roku sees Q1 revenue $478M-$493M, consensus $462.97M 02/18/21 Roku reports Q4 EPS 49c, consensus (5c) 02/18/21 Notable companies reporting after market close 11/05/20 Roku reports Q3 EPS 9c, consensus (40c) RDHL RedHill Biopharma $9.19 / -0.33 (-3.47%) 11/12/20 RedHill Biopharma reports Q3 EPS (5c), consenus (16c) OSUR OraSure $11.08 / +0.42 (+3.94%) 03/01/21 OraSure reports Q4 EPS 3c, consensus 7c 11/04/20 OraSure reports Q EPS 1c, consensus (7c) NVAX Novavax $239.73 / +8.52 (+3.68%) 03/01/21 Novavax reports Q4 EPS ($2.70), consensus ($1.49) 11/09/20 Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73 NLSN Nielsen $23.15 / +0.73 (+3.26%) 02/25/21 Nielsen sees FY21 adjusted EPS $1.43-$1.54, consensus $1.66 02/25/21 Nielsen reports Q4 adjusted EPS 53c, consensus 46c 02/24/21 Notable companies reporting before tomorrow's open NIO NIO $49.79 / +3.08 (+6.59%) 03/01/21 NIO sees Q1 revenue $1.13B-$1.16B, consensus $718.49M 03/01/21 NIO reports Q4 adjusted EPS (14c), consensus (7c) 11/17/20 NIO Inc. sees Q4 revenue $921.8M-$947.9M, consensus $805.66M 11/17/20 NIO Inc. reports Q3 adj. EPS (12c), consensus (17c) MREO Mereo BioPharma $3.96 / +0.07 (+1.80%) 09/29/20 Mereo BioPharma reports six months EPS (GBP1.05) vs. (22p) last year MORF Morphic $84.57 / +48.64 (+135.37%) 03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) MELI MercadoLibre $1,715.90 / +80.81 (+4.94%) 03/01/21 MercadoLibre reports Q4 EPS ($1.02), consensus 5c 11/04/20 MercadoLibre reports Q3 EPS 28c, consensus 17c LMND Lemonade $132.23 / +6.5 (+5.17%) 03/01/21 Lemonade sees FY21 revenue $114M-$117M, consensus $111.33M 03/01/21 Lemonade sees Q1 revenue $21.5M-$22.5M, consensus $22.11M 03/01/21 Lemonade reports Q4 EPS (60c), consensus (64c) INSG Inseego $15.00 / +0.35 (+2.39%) 03/01/21 Inseego reports Q4 EPS (14c), consensus 0c 11/05/20 Inseego reports Q3 adjusted EPS 1c, consensus (1c) INO Inovio $11.64 / +0.52 (+4.68%) 03/01/21 Inovio reports Q4 EPS (14c), consensus (22c) 11/09/20 Inovio reports Q3 EPS 11c, consensus (19c) HLIO Helios Technologies $67.14 / +1.295 (+1.97%) 03/01/21 Helios Technologies reports Q4 EPS 60c, consensus 41c 11/02/20 Helios Technologies sees FY20 revenue $485M-$495M, consensus $486.24M 11/02/20 Helios Technologies reports Q3 adjusted EPS 53c, consensus 41c FGEN FibroGen $50.35 / +0.38 (+0.76%) 03/01/21 FibroGen reports Q4 EPS (64c), consensus (24c) 11/05/20 FibroGen reports Q3 EPS 35c, consensus (80c) COHU Cohu $46.01 / +2.46 (+5.65%) 02/11/21 Cohu sees Q1 revenue $212M-$232M, consensus $207.9M 02/11/21 Cohu reports Q4 non-GAAP EPS 73c, consensus 61c 12/01/20 Cohu sees Q4 revenue $195M-$200M, consensus $186.26M 10/29/20 Cohu sees Q4 revenue $176M-$192M, consensus $142.64M BYND Beyond Meat $147.09 / +1.7 (+1.17%) 02/25/21 Beyond Meat reports Q4 adjusted EPS (34c), consensus (13c) 02/25/21 Notable companies reporting after market close 11/09/20 Beyond Meat reports Q3 adj. EPS (28c), consensus 5c 11/09/20 Notable companies reporting after market close ASLN Aslan Pharmaceuticals $5.22 / +0.82 (+18.64%) 11/09/20 Aslan Pharmaceuticals reports Q3 EPS (2c), two est. (9c) APPF AppFolio $160.72 / -4.985 (-3.01%) 03/01/21 AppFolio reports Q4 EPS (1c), consensus 7c 11/09/20 AppFolio reports Q3 EPS $3.86 vs. 14c last year AMRC Ameresco $60.46 / +3.18 (+5.55%) 03/01/21 Ameresco sees FY21 EPS $1.18-$1.26, consensus $1.22 03/01/21 Ameresco reports Q4 EPS 47c, consensus 29c 11/02/20 Ameresco raises FY20 adj. EPS view to 94c-$1.00 from 86c-96c 11/02/20 Ameresco reports Q3 adjusted EPS 38c, consensus 25c AI C3.ai $120.78 / +8.41 (+7.48%) 03/01/21 C3.ai reports Q3 EPS (13c), consensus (16c) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 03 Mar 03 Mar 03 Mar 02 Mar 10 Feb 21 Jan 13 Jan 14 Jan 14 Dec 09 Dec 31 Aug 02 Jul 11 Jun 03 Jun 27 May 06 May 17 Mar ZM SGMS ROKU NVAX NLSN NIO LMND INSG INO BYND ZM Zoom Video $409.67 / +35.805 (+9.58%) 12/23/20 Zoom Video developing web email service, Information reports 11/13/20 NYC mayor warns parents to plan for school shutdown, Bloomberg reports 11/10/20 Microsoft wants to demolish video-conferencing competition, BI reports 10/14/20 Zoom's Yuan says won't develop chat service to rival Slack, Bloomberg reports SGMS Scientific Games $50.79 / +3.84 (+8.18%) 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says ROKU Roku $420.23 / +25.095 (+6.35%) 02/16/21 Streaming device maker Roku is hiring to make original content, Protocol says 02/11/21 ViacomCBS working on '60 Minutes' spinoff for Paramount+, Bloomberg says 01/04/21 Roku in advanced talks to buy Quibi's content catalog, WSJ reports 12/02/20 Roku hires Apple's chief Siri architect Brian Pinkerton, Bloomberg reports NVAX Novavax $239.73 / +8.52 (+3.68%) 02/11/21 EU official tells Reuters Novavax vaccine deal is close 01/29/21 Novavax expects to make 150M vaccine doses per month by May/June, Reuters says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports 11/04/20 Novovax, Pfizer secure vaccine agreements with Australia, SMH reports NLSN Nielsen $23.15 / +0.73 (+3.26%) 10/27/20 Nielsen in talks with PE group about $2.9B sale of consumer goods unit, FT says NIO NIO $49.79 / +3.08 (+6.59%) 01/28/21 NIO ES6 'rumored to be coming to Europe in 2021,' Electrek says 01/06/21 NIO plans to launch models with lithium iron phosphate batteries, CNEVPost says 12/12/20 Nio, Xeng, Li Auto not the next Tesla, Barron's says 12/07/20 QuantumScape battery tech could be 'huge' for EVs, Barron's reports LMND Lemonade $132.23 / +6.5 (+5.17%) 01/14/21 Lemonade shares heading back to $100, Citron Research says 01/14/21 Citron cautious on Lemonade, says shares going back to $100 12/31/20 Short seller Friendly Bear sees Lemonade falling '90%+ in short order' INSG Inseego $15.00 / +0.35 (+2.39%) 09/22/20 Sequans may have lost Verizon as broadband customer, blog author claims INO Inovio $11.64 / +0.52 (+4.68%) 10/02/20 White House officials raise objections to FDA vaccine approval plans, WSJ says 09/29/20 Citron lowers Inovio price target to $2 after FDA hold news 09/23/20 U.K. to test vaccines on volunteers deliberately infected with COVID, FT reports 09/23/20 Inovio shares are going back to $5, Citron Research says BYND Beyond Meat $147.09 / +1.7 (+1.17%) 02/26/21 McDonald's clarifies to Bloomberg Beyond Meat's 'preferred supplier' status 02/04/21 Lawsuit challenging FDA approval of Impossible color additive, FSN reports 02/01/21 McDonald's begins introduction of McPlant Burger in test markets, Bloomberg says 11/09/20 Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant' ZM SRPT SGMS ROKU OSUR NVAX NLSN NIO MORF LMND INSG INO FGEN COHU BYND AI ZM Zoom Video $409.67 / +35.805 (+9.58%) 03/01/21 Fly Intel: What to watch in Zoom Video earnings report 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Pre-market Movers 12/30/20 #SocialStocks: Alleged Facebook, Google price-fixing under further investigation SRPT Sarepta $86.94 / -0.07 (-0.08%) 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Pre-market Movers SGMS Scientific Games $50.79 / +3.84 (+8.18%) 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting 02/05/21 Bet On It: Georgia online sports betting bill passes first test ROKU Roku $420.23 / +25.095 (+6.35%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/19/21 Fly Intel: Pre-market Movers 02/18/21 Fly Intel: After-Hours Movers OSUR OraSure $11.08 / +0.42 (+3.94%) 12/23/20 Fly Intel: Pre-market Movers 11/04/20 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: Pre-market Movers NVAX Novavax $239.73 / +8.52 (+3.68%) 02/11/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday NLSN Nielsen $23.15 / +0.73 (+3.26%) 11/02/20 Fly Intel: Wall Street's top stories for Monday 11/02/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: Pre-market Movers NIO NIO $49.79 / +3.08 (+6.59%) 02/24/21 Fly Intel: What to watch in Nvidia earnings report 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal 02/01/21 Piper more than doubles Tesla target as EV competitors report delivery numbers 02/01/21 Fly Intel: Pre-market Movers MORF Morphic $84.57 / +48.64 (+135.37%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday LMND Lemonade $132.23 / +6.5 (+5.17%) 12/28/20 Before the Move: Watch Lemonade into stock lockup expiration 11/11/20 Fly Intel: Pre-market Movers 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut INSG Inseego $15.00 / +0.35 (+2.39%) 11/05/20 Fly Intel: After-Hours Movers INO Inovio $11.64 / +0.52 (+4.68%) 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street 02/12/21 Fly Intel: Pre-market Movers 01/21/21 Fly Intel: Pre-market Movers 01/20/21 Fly Intel: After-Hours Movers FGEN FibroGen $50.35 / +0.38 (+0.76%) 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 12/21/20 Fly Intel: Pre-market Movers 09/03/20 Fly Intel: Pre-market Movers COHU Cohu $46.01 / +2.46 (+5.65%) 12/01/20 Fly Intel: After-Hours Movers BYND Beyond Meat $147.09 / +1.7 (+1.17%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 02/26/21 Fly Intel: Pre-market Movers 02/25/21 Fly Intel: After-Hours Movers AI C3.ai $120.78 / +8.41 (+7.48%) 01/04/21 Fly Intel: Pre-market Movers 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut 09/23/20 Fly Intel: After-Hours Movers 03/01/21 Technology Virtual Conference 2021 00:00 Today 41st Annual Healthcare Virtual Conference 03/04/21 M-Vest Virtual Conference Series: Late Stage Innovations in Women's Health 03/10/21 2021 Technology, Internet & Services Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/01/21 Morphic Holding - MORF 03/01/21 Aslan Pharmaceuticals - ASLN 03/01/21 Scientific Games - SGMS 03/01/21 Inovio - INO 03/01/21 Novavax - NVAX 03/01/21 Silk Road Medical - SILK 03/01/21 Ameresco - AMRC 03/01/21 Sarepta - SRPT 03/01/21 AppFolio - APPF 03/01/21 MercadoLibre - MELI 03/01/21 Zoom Video - ZM 03/01/21 C3.ai - AI 03/01/21 Inseego - INSG 03/01/21 OraSure - OSUR 03/01/21 FibroGen - FGEN 03/01/21 Switch - SWCH 03/01/21 SciPlay - SCPL 03/01/21 NIO - NIO 08:00 Today Lemonade - LMND 08:30 Today TTEC Holdings - TTEC 09:00 Today Helios Technologies - HLIO 16:30 Today TransMedics - TMDX 03/23/21 Cohu - COHU 03/20/21 PDUFA Date for Roxadustat--Extended Date 03/08/21 MercadoLibre 03/09/21 MercadoLibre ZM TMDX ROKU OSUR NVAX NLSN NIO LMND INSG INO FGEN BYND AI ZM Zoom Video $409.67 / +35.805 (+9.58%) 03/01/21 Zoom Video Communications options imply 15.8% move in share price post-earnings 02/05/21 Zoom Video Communications call volume above normal and directionally bullish 01/15/21 Zoom Video Communications call volume above normal and directionally bullish 01/12/21 Zoom Video Communications call volume above normal and directionally bullish TMDX TransMedics $36.30 / +0.33 (+0.92%) 09/02/20 Seven new option listings and two option delistings on September 2nd ROKU Roku $420.23 / +25.095 (+6.35%) 02/18/21 Roku options imply 13.2% move in share price post-earnings 01/07/21 Roku call volume above normal and directionally bullish 10/09/20 Unusual call flow in option market yesterday 10/08/20 Roku leads single-stock options after open as shares jump on upgrade OSUR OraSure $11.08 / +0.42 (+3.94%) 11/04/20 OraSure options imply 19.8% move in share price post-earnings NVAX Novavax $239.73 / +8.52 (+3.68%) 03/01/21 Novavax options imply 15.7% move in share price post-earnings 02/22/21 Million dollar long-shot call spread buyer in Noravax will cross earnings 11/27/20 Unusually active option classes on open November 27th 11/13/20 Novavax call volume above normal and directionally bullish NLSN Nielsen $23.15 / +0.73 (+3.26%) 12/04/20 Unusual call flow in option market yesterday 12/03/20 Bulls tune in to calls on Nielson Holdings 11/02/20 Early notable gainers among liquid option names on November 2nd 09/02/20 Early notable gainers among liquid option names on September 2nd NIO NIO $49.79 / +3.08 (+6.59%) 03/01/21 NIO options imply 16.3% move in share price post-earnings 02/24/21 Notable open interest changes for February 24th 02/19/21 Notable open interest changes for February 19th 02/17/21 Notable open interest changes for February 17th LMND Lemonade $132.23 / +6.5 (+5.17%) 01/22/21 Largest borrow rate increases among liquid names 01/21/21 Largest borrow rate increases among liquid names 01/15/21 Largest borrow rate increases among liquid names 01/07/21 Largest borrow rate increases among liquid names INSG Inseego $15.00 / +0.35 (+2.39%) 02/19/21 Inseego call volume above normal and directionally bullish 01/26/21 Inseego put volume heavy and directionally bearish 01/26/21 Unusually active option classes on open January 26th 12/15/20 Largest borrow rate increases among liquid names INO Inovio $11.64 / +0.52 (+4.68%) 03/01/21 Inovio options imply 19.7% move in share price post-earnings 02/23/21 Inovio put volume heavy and directionally bearish 02/12/21 Unusually active option classes on open February 12th 02/01/21 Inovio call volume above normal and directionally bullish FGEN FibroGen $50.35 / +0.38 (+0.76%) 10/12/20 Unusually active option classes on open October 12th BYND Beyond Meat $147.09 / +1.7 (+1.17%) 01/25/21 Beyond Meat call volume above normal and directionally bullish 01/22/21 Beyond Meat call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names 11/18/20 Unusually active option classes on open November 18th AI C3.ai $120.78 / +8.41 (+7.48%) 02/09/21 C3 AI call volume above normal and directionally bullish 02/02/21 C3 AI call volume above normal and directionally bullish 01/06/21 Largest borrow rate increases among liquid names 12/15/20 Two new option listings on December 15th
On The Fly	Fly Intel: Wall Street's top stories for Monday » 16:45 03/01/21 03/01 16:45 03/01/21 16:45 JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) , XOM Exxon Mobil $56.40 / +2.02 (+3.71%) , OTRK Ontrak $31.62 / -27.515 (-46.53%) , ATNX Athenex $5.47 / -6.715 (-55.11%) , DKNG DraftKings $68.71 / +7.24 (+11.78%) , MORF Morphic $84.57 / +48.64 (+135.37%) The three major averages… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XOM OTRK MORF JNJ DKNG ATNX XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 OTRK Ontrak $31.62 / -27.515 (-46.53%) 10/29/20 Ontrak acquires behavior change platform LifeDojo 10/13/20 Ontrak rises after announcing launch of Ontrak-CI program MORF Morphic $84.57 / +48.64 (+135.37%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/26/21 DraftKings MUPs for B2C segment up 44% vs. 4Q19 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/25/21 DraftKings names Cal Ripken Jr. as special advisor to board of directors ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 Athenex trading resumes 03/01/21 Athenex expects cash to fund operations into 2Q22 03/01/21 Athenex announces key anticipated future milestones 03/01/21 FDA requests new study from Athenex for oral paclitaxel plus encequidar JNJ XOM OTRK ATNX DKNG MORF JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas OTRK Ontrak $31.62 / -27.515 (-46.53%) 03/01/21 RBC Capital RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna 03/01/21 RBC Capital Ontrak downgraded to Sector Perform from Outperform at RBC Capital 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/04/21 B. Riley Securities Ontrak price target raised to $110 from $100 at B. Riley Securities ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 JPMorgan JPMorgan downgrades Athenex on 'huge surprise' from FDA 03/01/21 SVB Leerink Athenex downgraded to Market Perform from Outperform at SVB Leerink 03/01/21 JPMorgan Athenex downgraded to Neutral from Overweight at JPMorgan 03/01/21 Laidlaw Athenex price target lowered to $13 from $38 at Laidlaw DKNG DraftKings $68.71 / +7.24 (+11.78%) 03/01/21 Craig-Hallum DraftKings price target raised to $70 from $65 at Craig-Hallum 03/01/21 Canaccord DraftKings price target raised to $80 from $65 at Canaccord 03/01/21 Northland DraftKings price target raised to $70 from $55 at Northland 03/01/21 Benchmark DraftKings price target raised to $69 from $66 at Benchmark MORF Morphic $84.57 / +48.64 (+135.37%) 03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital XOM OTRK MORF JNJ DKNG ATNX XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices OTRK Ontrak $31.62 / -27.515 (-46.53%) 03/01/21 Ontrak sees FY21 revenue $100M, consensus $165.05M 03/01/21 Ontrak reports Q4 EPS (7c), consensus (30c) 11/05/20 Ontrak reports Q3 EPS (36c), consensus (35c) MORF Morphic $84.57 / +48.64 (+135.37%) 03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/26/21 DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M 02/26/21 DraftKings reports Q4 revenue $322M, consensus $232.6M 02/25/21 Notable companies reporting before tomorrow's open ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c) 07 Oct 10 Sep 19 Jun XOM JNJ DKNG XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 03/01/21 Ubben, Angelakis to join board of Exxon Mobil, CNBC reports 02/17/21 Texas prohibits natgas firms from taking fuel out of state, Bloomberg says 02/17/21 Saudis to raise oil output as prices recover, WSJ reports 02/05/21 Exxon considering nominating Jeff Ubben to board, CNBC reports JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/28/21 DraftKings to bring sportsbook, casino apps to Google Play, 9to5Google says 01/28/21 DraftKings sportsbook, casino apps soon available via Google Play, Reuters says XOM OTRK JNJ DKNG ATNX XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 02/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/02/21 Fly Intel: Wall Street's top stories at midday OTRK Ontrak $31.62 / -27.515 (-46.53%) 03/01/21 Ontrak plunges after announcing loss of Aetna contract JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/26/21 Fly Intel: Wall Street's top stories at midday 02/26/21 Fly Intel: Pre-market Movers ATNX Athenex $5.47 / -6.715 (-55.11%) 12/15/20 Fly Intel: Pre-market Movers 09/21/20 Fly Insider: Kingsway Financial, Nvidia among week's notable insider trades 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 03/01/21 26th Annual Energy Virtual Summit 00:00 Today 41st Annual Healthcare Virtual Conference 03/01/21 Athenex - ATNX 03/01/21 Morphic Holding - MORF 03/09/21 Ontrak - OTRK 04/20/21 Johnson & Johnson - JNJ 03/03/21 Exxon Mobil Corp. 03/09/21 DraftKings Inc XOM OTRK JNJ DKNG XOM Exxon Mobil $56.40 / +2.02 (+3.71%) 02/09/21 Unusually active option classes on open February 9th 02/08/21 Exxon Mobil call volume above normal and directionally bullish 02/08/21 Unusually active option classes on open February 8th OTRK Ontrak $31.62 / -27.515 (-46.53%) 10/12/20 Largest borrow rate increases among liquid names 09/16/20 Ontrak put volume heavy and directionally bearish 09/15/20 Ontrak put volume heavy and directionally bearish JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th DKNG DraftKings $68.71 / +7.24 (+11.78%) 02/02/21 DraftKings call volume above normal and directionally bullish 01/27/21 DraftKings call volume above normal and directionally bullish 01/26/21 DraftKings call volume above normal and directionally bullish 01/12/21 DraftKings call volume above normal and directionally bullish
Earnings	Novavax reports Q4 EPS ($2.70), consensus ($1.49) » 16:11 03/01/21 03/01 16:11 03/01/21 16:11 NVAX Novavax $239.35 / +8.14 (+3.52%) Reports Q4 revenue… Reports Q4 revenue $279.7M, consensus $304.88M. "Novavax continues to make significant strides towards bringing NVX-CoV2373, our COVID-19 vaccine candidate, to market," said Stanley C. Erck, President and Chief Executive Officer of Novavax. "With positive efficacy results, including against evolving variant strains, NVX-CoV2373 offers a highly unique profile, including the ability to ship and store the vaccine at traditional refrigerated temperatures. We believe these attributes support emergency use authorization and have initiated dialogue with regulators to pursue appropriate regulatory authorization. In addition, we have secured agreements for the delivery of approximately 300 million doses of NVX-CoV2373. In our efforts to provide fair and equitable access to our vaccine around the world, we are proud to partner with the Serum Institute of India to jointly supply 1.1 billion doses of NVX-CoV2373 to Gavi through the COVAX Facility. We continue to work tirelessly to make final commercial preparations in advance of delivering our product across the globe." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NVAX Novavax $239.35 / +8.14 (+3.52%) 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 Novavax completes enrollment of PREVENT-19 Phase 3 trial NVAX Novavax $239.35 / +8.14 (+3.52%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/22/21 Cantor Fitzgerald Cantor says PREVENT-19 gives Novavax potential for differentiated analyses 02/22/21 B. Riley Securities B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up 02/18/21 B. Riley Securities Novavax price target raised to $397 from $334 at B. Riley Securities NVAX Novavax $239.35 / +8.14 (+3.52%) 11/09/20 Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73 NVAX Novavax $239.35 / +8.14 (+3.52%) 02/11/21 EU official tells Reuters Novavax vaccine deal is close 01/29/21 Novavax expects to make 150M vaccine doses per month by May/June, Reuters says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports 11/04/20 Novovax, Pfizer secure vaccine agreements with Australia, SMH reports NVAX Novavax $239.35 / +8.14 (+3.52%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 03/01/21 Novavax - NVAX NVAX Novavax $239.35 / +8.14 (+3.52%) 03/01/21 Novavax options imply 15.7% move in share price post-earnings 02/22/21 Million dollar long-shot call spread buyer in Noravax will cross earnings 11/27/20 Unusually active option classes on open November 27th 11/13/20 Novavax call volume above normal and directionally bullish
Hot Stocks	FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA » 16:06 03/01/21 03/01 16:06 03/01/21 16:06 FGEN FibroGen $50.19 / +0.22 (+0.44%) , AZN AstraZeneca $48.21 / -0.14 (-0.29%) FibroGen (FGEN) and its… FibroGen (FGEN) and its partner, AstraZeneca (AZN), announced that the Cardiovascular and Renal Drugs Advisory Committee of the FDA will hold an advisory committee, or AdCom, meeting to review the new drug application for roxadustat in the U.S. The companies have not received a confirmed AdCom meeting date from the FDA. "While disappointed with the news today, FibroGen and AstraZeneca are committed to working with the FDA to bring roxadustat to patients with anemia of CKD in the U.S. as soon as possible," said Enrique Conterno, CEO, FibroGen. "We continue to be confident in the efficacy and safety profile of this potential new medicine based on positive results from a global Phase 3 program encompassing more than 8,000 patients." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FGEN AZN FGEN FibroGen $50.19 / +0.22 (+0.44%) 12/22/20 FibroGen doses first patient in ZEPHYRUS-2 Phase 3 study of pamrevlumab 12/19/20 AstraZeneca updates on U.S. regulatory review of roxadustat 12/18/20 FibroGen says FDA extends review period for roxadustat NDA 12/02/20 FibroGen to present Roxadustat Phase 3 analyses at ASH meeting AZN AstraZeneca $48.21 / -0.14 (-0.29%) 02/26/21 Amgen, AstraZeneca report 'positive' results from NAVIGATOR Phase 3 trial 02/24/21 ChemoCentryx appoints Tausif Butt as EVP, COO 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 AstraZeneca notes U.S. withdrawal of Imfinzi advanced bladder cancer indication FGEN AZN FGEN FibroGen $50.19 / +0.22 (+0.44%) 02/01/21 H.C. Wainwright FibroGen initiated with a Buy at H.C. Wainwright 12/21/20 Mizuho FibroGen should be bought on PDUFA extension weakness, says Mizuho 10/26/20 Raymond James FibroGen initiated with an Underperform at Raymond James 10/26/20 Raymond James FibroGen initiated with an Underperform at Raymond James AZN AstraZeneca $48.21 / -0.14 (-0.29%) 02/25/21 Fly Intel: Top five analyst upgrades 02/25/21 UBS AstraZeneca upgraded to Buy from Neutral at UBS 02/04/21 Piper Sandler Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' FGEN AZN FGEN FibroGen $50.19 / +0.22 (+0.44%) 03/01/21 FibroGen reports Q4 EPS (64c), consensus (24c) 11/05/20 FibroGen reports Q3 EPS 35c, consensus (80c) AZN AstraZeneca $48.21 / -0.14 (-0.29%) 02/11/21 AstraZeneca sees FY21 core EPS $4.75-$5.00 02/11/21 AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year AZN AZN AstraZeneca $48.21 / -0.14 (-0.29%) 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 Germany to receive 16M AstraZeneca Covid vaccines in Q2, Reuters reports 02/23/21 AstraZeneca: COVID-19 vaccine could receive U.S. EUA by April, Reuters says FGEN AZN FGEN FibroGen $50.19 / +0.22 (+0.44%) 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 12/21/20 Fly Intel: Pre-market Movers 09/03/20 Fly Intel: Pre-market Movers AZN AstraZeneca $48.21 / -0.14 (-0.29%) 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Fly Intel: Wall Street's top stories for Monday 02/08/21 Fly Intel: Wall Street's top stories at midday 00:00 Today 41st Annual Healthcare Virtual Conference 00:00 Today 2021 London Global Healthcare Virtual Conference 03/01/21 FibroGen - FGEN 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease FGEN AZN FGEN FibroGen $50.19 / +0.22 (+0.44%) 10/12/20 Unusually active option classes on open October 12th AZN AstraZeneca $48.21 / -0.14 (-0.29%) 02/24/21 AstraZeneca call volume above normal and directionally bullish 02/17/21 AstraZeneca call volume above normal and directionally bullish 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th
Conference/Events	Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 15:48 03/01/21 03/01 15:48 03/01/21 15:48 ADVM Adverum Biotechnologies $13.31 / +0.455 (+3.54%) , UBX Unity Biotechnology $7.53 / +0.7 (+10.25%) , AGTC Applied Genetic $5.64 / +0.54 (+10.59%) , JNJ Johnson & Johnson $159.50 / +1.08 (+0.68%) , MGTX MeiraGTx $15.21 / +0.4 (+2.70%) , NITE Nightstar Therapeutics $25.41 / + (+0.00%) , BIIB Biogen $272.79 / -0.16 (-0.06%) , AERI Aerie Pharmaceuticals $19.36 / +0.96 (+5.22%) , ALDX Aldeyra $12.20 / -0.05 (-0.41%) Biopharmaceuticals… Biopharmaceuticals Analyst Chen, along with Dr. Ruchita Amin, Retina Specialist at Retina Vitreous Associates and Dr. Roger Goldberg, Partner and Vitreoretinal Surgeon at Bay Area Retina Associates, discuss hot topics and key 2021 focus areas in eye diseases on an Analyst/Industry Conference Call to be held on March 8 at 1 pm. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Rumors Options UBX MGTX JNJ BIIB ALDX AGTC AERI ADVM UBX Unity Biotechnology $7.53 / +0.7 (+10.25%) 02/24/21 Unity Biotechnology reports granting of employment inducement awards 02/08/21 Unity Biotechnology's UBX1325 shows eye disease treatment potential in study 02/03/21 Unity Biotechnology reports granting of employment inducement awards 02/01/21 Unity Biotechnology appoints Mike Sapieha as Chief Scientific Advisor MGTX MeiraGTx $15.21 / +0.4 (+2.70%) 01/26/21 MeiraGTx granted fast track designation for AAV-CNGA3 11/13/20 MeiraGTx gene therapy demonstrates improvement in XLRP 10/04/20 MeiraGTx announces 9-month data from Phase 1/2 Trial of AAV-RPGR JNJ Johnson & Johnson $159.50 / +1.08 (+0.68%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA BIIB Biogen $272.79 / -0.16 (-0.06%) 02/03/21 Biogen sees FY21 adjusted R&D expense $2.35B-$2.45B 02/03/21 Biogen CEO sees 'a financial reset in 2021' 02/01/21 Biogen announces FDA approval of PLEGRIDY intramuscular administration 01/29/21 Biogen, Eisai announce 3-month extension of review period for aducanumab BLA ALDX Aldeyra $12.20 / -0.05 (-0.41%) 02/04/21 Aldeyra announces Phase 3 TRANQUILITY dry eye disease trial design 01/21/21 Aldeyra rises 6% after 1.37M share purchase disclosed by Perceptive Advisors 01/07/21 Aldeyra announces top-line results from run-in cohort in Tranquility study 12/22/20 Aldeyra confirms SARS-CoV-2 antiviral activity of ADX-1612 AGTC Applied Genetic $5.64 / +0.54 (+10.59%) 02/11/21 Applied Genetic expects cash, cash equivalents to fund programs into 2023 11/11/20 Applied Genetic reports additional data from Phase 1/2 trial in XLRP 10/07/20 Applied Genetic joins My Retina Tracker program as scientific collaborator 09/09/20 Applied Genetic on track for data readouts for ACHM program in Q4 AERI Aerie Pharmaceuticals $19.36 / +0.96 (+5.22%) 01/11/21 Aerie Pharmaceuticals receives EC marketing approval for Roclanda 11/13/20 Aerie Pharmaceuticals' Roclanda receives positive CHMP opinion in the EU 10/29/20 Aerie Pharmaceuticals initiates Phase 2b trial AR-15512 10/28/20 Aerie, Santen enter exclusive agreement for Rhopressa and Rocklatan in Japan ADVM Adverum Biotechnologies $13.31 / +0.455 (+3.54%) 02/22/21 Adverum appoints Reed Tuckson to board of directors 02/02/21 Adverum announces publication of safety data on ADVM-022 gene therapy 01/11/21 Adverum Biotechnologies announces 2021 focus areas 01/11/21 Adverum Biotechnologies completes patient enrollment for INFINITY Phase 2 trial ADVM UBX AGTC JNJ MGTX NITE BIIB AERI ALDX ADVM Adverum Biotechnologies $13.31 / +0.455 (+3.54%) 12/15/20 UBS Adverum Biotechnologies initiated with a Neutral at UBS 11/15/20 Piper Sandler Adverum Biotechnologies shares should grind higher over time, says Piper Sandler 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform at Raymond James UBX Unity Biotechnology $7.53 / +0.7 (+10.25%) 02/16/21 Citi Unity Biotechnology downgraded to Sell from Neutral at Citi 08/18/20 Fly Intel: Top five analyst downgrades 08/18/20 Morgan Stanley Unity Biotechnology downgraded at Morgan Stanley as UBX101 doesn't meet endpoint 08/18/20 Citi Unity Biotechnology downgraded to Neutral from Buy at Citi AGTC Applied Genetic $5.64 / +0.54 (+10.59%) 02/02/21 H.C. Wainwright Applied Genetic price target raised to $24 from $18 at H.C. Wainwright 02/01/21 Roth Capital Applied Genetic price target raised to $35 from $30 at Roth Capital 11/17/20 Roth Capital Applied Genetic price target raised to $30 from $26 at Roth Capital 11/11/20 H.C. Wainwright Applied Genetic XLRP data 'continue to impress,' says H.C. Wainwright JNJ Johnson & Johnson $159.50 / +1.08 (+0.68%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MGTX MeiraGTx $15.21 / +0.4 (+2.70%) 02/16/21 Chardan MeiraGTx called a Top Pick for 2021 at Chardan 12/17/20 Chardan Chardan boosts MeiraGTx target to $55, say buy shares 'now' 12/17/20 Piper Sandler Piper says MeiraGTx not getting credit for RIX gene therapy that 'clearly works' 10/22/20 RBC Capital MeiraGTx initiated with an Outperform at RBC Capital NITE Nightstar Therapeutics $25.41 / + (+0.00%) BIIB Biogen $272.79 / -0.16 (-0.06%) 02/17/21 Cantor Fitzgerald Biogen price target lowered to $268 from $278 at Cantor Fitzgerald 02/08/21 Citi Expert sees Biogen aducanumab approval 50/50 at best, says Citi 02/04/21 SVB Leerink Biogen price target lowered to $380 from $430 at SVB Leerink 02/04/21 Credit Suisse Biogen price target lowered to $338 from $350 at Credit Suisse AERI Aerie Pharmaceuticals $19.36 / +0.96 (+5.22%) 11/09/20 H.C. Wainwright Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright 10/28/20 H.C. Wainwright Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright 10/19/20 BofA Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA 10/19/20 BofA Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA ALDX Aldeyra $12.20 / -0.05 (-0.41%) 02/08/21 H.C. Wainwright Aldeyra initiated with a Buy at H.C. Wainwright 01/28/21 JonesTrading Aldeyra assumed with a Buy at JonesTrading 01/08/21 Jefferies Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies 01/08/21 Citi Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi UBX MGTX JNJ BIIB ALDX AGTC AERI ADVM UBX Unity Biotechnology $7.53 / +0.7 (+10.25%) 11/04/20 Unity Biotechnology reports Q3 EPS (52c), consensus (49c) MGTX MeiraGTx $15.21 / +0.4 (+2.70%) 11/05/20 MeiraGTx reports Q3 EPS (17c), consensus (70c) 10/28/20 MeiraGTx to present data on phase 1/2 clinical trial on AAV-RPGR JNJ Johnson & Johnson $159.50 / +1.08 (+0.68%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open BIIB Biogen $272.79 / -0.16 (-0.06%) 02/03/21 Biogen sees FY21 adjusted EPS $17.00-$18.50, consensus $24.67 02/03/21 Biogen reports Q4 adjusted EPS $4.58, consensus $4.87 02/02/21 Notable companies reporting before tomorrow's open ALDX Aldeyra $12.20 / -0.05 (-0.41%) 11/05/20 Aldeyra reports Q3 EPS (23c), consensus (27c) AGTC Applied Genetic $5.64 / +0.54 (+10.59%) 02/11/21 Applied Genetic reports Q4 EPS (60c), consensus (59c) 11/16/20 Applied Genetic reports Q4 EPS (60c), consensus (53c) 09/09/20 Applied Genetic reports Q4 EPS (56c), consensus (48c) AERI Aerie Pharmaceuticals $19.36 / +0.96 (+5.22%) 02/25/21 Aerie Pharmaceuticals reports Q4 EPS (79c), consensus (73c) 11/05/20 Aerie Pharmaceuticals reports Q3 EPS (86c), consensus (80c) ADVM Adverum Biotechnologies $13.31 / +0.455 (+3.54%) 11/05/20 Adverum Biotechnologies reports Q3 EPS (31c), consensus (34c) 28 Jan 14 Jan 19 Nov 13 Aug JNJ BIIB JNJ Johnson & Johnson $159.50 / +1.08 (+0.68%) 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports BIIB Biogen $272.79 / -0.16 (-0.06%) 11/07/20 Biogen Alzheimer's drug closer to approval, still not a buy, Barron's says 11/07/20 FDA may find it 'extremely' hard to approve Biogen drug after panel, STAT says 09/28/20 Biogen loses appeal in fight seeking royalties from Merck KGaA, Bloomberg says 09/28/20 Biogen loses appeal ruling on MS drug Rebif, Bloomberg says UBX JNJ BIIB ALDX AGTC AERI UBX Unity Biotechnology $7.53 / +0.7 (+10.25%) 09/16/20 Fly Intel: After-Hours Movers JNJ Johnson & Johnson $159.50 / +1.08 (+0.68%) 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday BIIB Biogen $272.79 / -0.16 (-0.06%) 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers 01/29/21 Fly Intel: Wall Street's top stories for Friday ALDX Aldeyra $12.20 / -0.05 (-0.41%) 01/25/21 Fly Insider: OncoCyte, Air Transport among week's notable insider trades 01/21/21 Fly Intel: After-Hours Movers AGTC Applied Genetic $5.64 / +0.54 (+10.59%) 11/11/20 Hilton upgrade, AIG downgrade among today's top calls on Wall Street AERI Aerie Pharmaceuticals $19.36 / +0.96 (+5.22%) 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/19/20 Fly Intel: Wall Street's top stories at midday 09/15/20 Fly Intel: Pre-market Movers 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 00:00 Today 41st Annual Healthcare Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/01/21 Adverum Biotechnologies - ADVM 04/20/21 Johnson & Johnson - JNJ 06/07/21 PDUFA Date for Aducanumab BIIB BIIB Biogen $272.79 / -0.16 (-0.06%) 09/15/20 Alexion strength attributed to takeover speculation JNJ BIIB JNJ Johnson & Johnson $159.50 / +1.08 (+0.68%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th BIIB Biogen $272.79 / -0.16 (-0.06%) 01/29/21 Early notable gainers among liquid option names on January 29th 01/08/21 Biogen put volume heavy and directionally bearish 11/11/20 Early notable gainers among liquid option names on November 11th 11/05/20 Unusually active option classes on open November 5th

Options	Novavax options imply 15.7% move in share price post-earnings » 15:34 03/01/21 03/01 15:34 03/01/21 15:34 NVAX Novavax $237.35 / +6.14 (+2.66%) Pre-earnings options… Pre-earnings options volume in Novavax is normal with calls leading puts 19:7. Implied volatility suggests the market is anticipating a move near 15.7%, or $37.46, after results are released. Median move over the past eight quarters is 10.9%. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NVAX Novavax $237.35 / +6.14 (+2.66%) 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 Novavax completes enrollment of PREVENT-19 Phase 3 trial NVAX Novavax $237.35 / +6.14 (+2.66%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/22/21 Cantor Fitzgerald Cantor says PREVENT-19 gives Novavax potential for differentiated analyses 02/22/21 B. Riley Securities B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up 02/18/21 B. Riley Securities Novavax price target raised to $397 from $334 at B. Riley Securities NVAX Novavax $237.35 / +6.14 (+2.66%) 11/09/20 Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73 NVAX Novavax $237.35 / +6.14 (+2.66%) 02/11/21 EU official tells Reuters Novavax vaccine deal is close 01/29/21 Novavax expects to make 150M vaccine doses per month by May/June, Reuters says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports 11/04/20 Novovax, Pfizer secure vaccine agreements with Australia, SMH reports NVAX Novavax $237.35 / +6.14 (+2.66%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 03/01/21 Novavax - NVAX NVAX Novavax $237.35 / +6.14 (+2.66%) 02/22/21 Million dollar long-shot call spread buyer in Noravax will cross earnings 11/27/20 Unusually active option classes on open November 27th 11/13/20 Novavax call volume above normal and directionally bullish 11/12/20 Novavax call volume above normal and directionally bullish
On The Fly	Fly Intel: Wall Street's top stories at midday » 12:23 03/01/21 03/01 12:23 03/01/21 12:23 JNJ Johnson & Johnson $160.50 / +2.08 (+1.31%) , XOM Exxon Mobil $57.12 / +2.74 (+5.04%) , OTRK Ontrak $30.17 / -28.96 (-48.98%) , ATNX Athenex $5.78 / -6.41 (-52.61%) , GRPN Groupon $59.42 / +16.18 (+37.42%) , MORF Morphic Holding $74.48 / +38.55 (+107.29%) The major averages are… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XOM OTRK MORF JNJ GRPN ATNX XOM Exxon Mobil $57.12 / +2.74 (+5.04%) 03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 OTRK Ontrak $30.17 / -28.96 (-48.98%) 10/29/20 Ontrak acquires behavior change platform LifeDojo 10/13/20 Ontrak rises after announcing launch of Ontrak-CI program MORF Morphic Holding $74.48 / +38.55 (+107.29%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen JNJ Johnson & Johnson $160.50 / +2.08 (+1.31%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA GRPN Groupon $59.42 / +16.18 (+37.42%) 02/25/21 Groupon: Local billings in NA are down 49% y/y quarter-to-date 02/25/21 Groupon on track to take $225M of fixed cost base by 2022 11/06/20 Groupon 'well on our way' to achieving 2022 cost savings 11/06/20 Groupon taking a global approach to marketing campaigns for holidays ATNX Athenex $5.78 / -6.41 (-52.61%) 03/01/21 Athenex trading resumes 03/01/21 Athenex expects cash to fund operations into 2Q22 03/01/21 Athenex announces key anticipated future milestones 03/01/21 FDA requests new study from Athenex for oral paclitaxel plus encequidar JNJ XOM OTRK ATNX GRPN MORF JNJ Johnson & Johnson $160.50 / +2.08 (+1.31%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' XOM Exxon Mobil $57.12 / +2.74 (+5.04%) 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas OTRK Ontrak $30.17 / -28.96 (-48.98%) 03/01/21 RBC Capital RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna 03/01/21 RBC Capital Ontrak downgraded to Sector Perform from Outperform at RBC Capital 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/04/21 B. Riley Securities Ontrak price target raised to $110 from $100 at B. Riley Securities ATNX Athenex $5.78 / -6.41 (-52.61%) 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Evercore ISI Athenex initiated with an Outperform at Evercore ISI 10/26/20 Fly Intel: Top five analyst initiations 10/26/20 SVB Leerink Athenex initiated with an Outperform at SVB Leerink GRPN Groupon $59.42 / +16.18 (+37.42%) 03/01/21 JPMorgan JPMorgan upgrades Groupon to Neutral on new marketplace strategy 03/01/21 JPMorgan Groupon upgraded to Neutral from Underweight at JPMorgan 01/04/21 Barclays Groupon assumed with an Underweight at Barclays 11/02/20 Wedbush Groupon price target lowered to $21 from $27 at Wedbush MORF Morphic Holding $74.48 / +38.55 (+107.29%) 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital XOM OTRK MORF JNJ GRPN ATNX XOM Exxon Mobil $57.12 / +2.74 (+5.04%) 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices OTRK Ontrak $30.17 / -28.96 (-48.98%) 03/01/21 Ontrak sees FY21 revenue $100M, consensus $165.05M 03/01/21 Ontrak reports Q4 EPS (7c), consensus (30c) 11/05/20 Ontrak reports Q3 EPS (36c), consensus (35c) MORF Morphic Holding $74.48 / +38.55 (+107.29%) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) JNJ Johnson & Johnson $160.50 / +2.08 (+1.31%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open GRPN Groupon $59.42 / +16.18 (+37.42%) 02/25/21 Groupon sees FY21 revenue $930M-$980M, consensus $945.35M 02/25/21 Groupon reports Q4 adjusted EPS 51c consensus 26c 11/05/20 Groupon reports Q3 adjusted EPS 15c, consensus (95c) ATNX Athenex $5.78 / -6.41 (-52.61%) 03/01/21 Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c) 10 Sep XOM JNJ XOM Exxon Mobil $57.12 / +2.74 (+5.04%) 03/01/21 Ubben, Angelakis to join board of Exxon Mobil, CNBC reports 02/17/21 Texas prohibits natgas firms from taking fuel out of state, Bloomberg says 02/17/21 Saudis to raise oil output as prices recover, WSJ reports 02/05/21 Exxon considering nominating Jeff Ubben to board, CNBC reports JNJ Johnson & Johnson $160.50 / +2.08 (+1.31%) 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports XOM OTRK JNJ GRPN ATNX XOM Exxon Mobil $57.12 / +2.74 (+5.04%) 02/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/02/21 Fly Intel: Wall Street's top stories at midday 02/02/21 Fly Intel: Pre-market Movers OTRK Ontrak $30.17 / -28.96 (-48.98%) 03/01/21 Ontrak plunges after announcing loss of Aetna contract JNJ Johnson & Johnson $160.50 / +2.08 (+1.31%) 03/01/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday GRPN Groupon $59.42 / +16.18 (+37.42%) 03/01/21 Twitter, Wayfair upgrades among today's top calls on Wall Street 02/25/21 Fly Intel: After-Hours Movers 11/06/20 Fly Intel: Wall Street's top stories for Friday 11/06/20 Fly Intel: Wall Street's top stories at midday ATNX Athenex $5.78 / -6.41 (-52.61%) 12/15/20 Fly Intel: Pre-market Movers 09/21/20 Fly Insider: Kingsway Financial, Nvidia among week's notable insider trades 09/10/20 Fly Intel: Pre-market Movers 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 03/01/21 26th Annual Energy Virtual Summit 00:00 Today 41st Annual Healthcare Virtual Conference 03/01/21 Athenex - ATNX 03/01/21 Morphic Holding - MORF 03/09/21 Ontrak - OTRK 04/20/21 Johnson & Johnson - JNJ 03/03/21 Exxon Mobil Corp. XOM OTRK JNJ GRPN XOM Exxon Mobil $57.12 / +2.74 (+5.04%) 02/09/21 Unusually active option classes on open February 9th 02/08/21 Exxon Mobil call volume above normal and directionally bullish 02/08/21 Unusually active option classes on open February 8th OTRK Ontrak $30.17 / -28.96 (-48.98%) 10/12/20 Largest borrow rate increases among liquid names 09/16/20 Ontrak put volume heavy and directionally bearish 09/15/20 Ontrak put volume heavy and directionally bearish JNJ Johnson & Johnson $160.50 / +2.08 (+1.31%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th GRPN Groupon $59.42 / +16.18 (+37.42%) 11/17/20 Groupon put volume heavy and directionally bearish 11/17/20 Largest borrow rate increases among liquid names 11/16/20 Groupon put volume heavy and directionally bearish
Options	Moderna call volume above normal and directionally bullish » 11:45 03/01/21 03/01 11:45 03/01/21 11:45 MRNA Moderna $147.15 / -7.75 (-5.00%) Bullish option flow… Bullish option flow detected in Moderna with 22,687 calls trading, 1.0x expected, and implied vol increasing over 1 point to 75.16%. Jul-21 170 calls and 3/12 weekly 220 calls are the most active options, with total volume in those strikes near 5,500 contracts. The Put/Call Ratio is 0.48. Earnings are expected on May 5th. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA Moderna $147.15 / -7.75 (-5.00%) 02/25/21 Moderna's chief medical officer Tal Zaks to leave company in late September 02/24/21 Moderna makes new capital investment to boost manufacturing capacity 02/24/21 Moderna ships mRNA-1273.351 to NIH for clinical study 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan MRNA Moderna $147.15 / -7.75 (-5.00%) 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline 02/25/21 Piper Sandler Moderna transitioning into profitable company, says Piper Sandler MRNA Moderna $147.15 / -7.75 (-5.00%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA Moderna $147.15 / -7.75 (-5.00%) 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/12/21 FDA tells Moderna it can boost vaccine supply in each vial, NY Times reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says MRNA Moderna $147.15 / -7.75 (-5.00%) 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday 03/16/21 31st Annual Healthcare Virtual Conference MRNA Moderna $147.15 / -7.75 (-5.00%) 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish 11/27/20 Moderna call buyer realizes 22% same-day gains
Options	Unusually active option classes on open March 1st » 09:40 03/01/21 03/01 09:40 03/01/21 09:40 RCL Royal Caribbean $93.43 / + (+0.00%) , NRG NRG Energy $36.50 / + (+0.00%) , JNJ Johnson & Johnson $158.52 / +0.1 (+0.06%) , PBR Petrobras $7.92 / + (+0.00%) , XOM Exxon Mobil $54.38 / + (+0.00%) , RKT Rocket Companies $21.84 / + (+0.00%) , C Citi $65.86 / + (+0.00%) , BA Boeing $212.02 / + (+0.00%) , WMT Walmart $129.87 / -0.02 (-0.02%) , PENN Penn National $115.83 / +0.02 (+0.02%) Unusual total active… Unusual total active option classes on open include: Royal Caribbean (RCL), NRG Energy (NRG), Johnson & Johnson (JNJ), Petrobras (PBR), Exxon Mobil (XOM), Rocket Companies (RKT), Citi (C), Boeing (BA), Wal-Mart (WMT), and Penn National (PENN). ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XOM WMT RKT RCL PENN PBR NRG JNJ C BA XOM Exxon Mobil $54.38 / + (+0.00%) 03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 WMT Walmart $129.87 / -0.02 (-0.02%) 03/01/21 Walmart drops $35 minimum for express delivery 02/24/21 BigCommerce announces Walmart Marketplace partnership for merchants 02/18/21 Walmart sees Q1 EPS flat to slightly up vs. last year, consensus $1.30 02/18/21 Walmart to execute new $20B buyback program 'over next 3 years or so' RKT Rocket Companies $21.84 / + (+0.00%) 02/25/21 Rocket Companies announces special dividend of $1.11 per share 02/25/21 Rocket Companies sees Q1 closed loan volume $98B-$103B 11/11/20 Rocket Companies CEO: Our platform allows us to scale 11/10/20 Rocket Companies approves $1B share repurchase program RCL Royal Caribbean $93.43 / + (+0.00%) 03/01/21 Royal Caribbean to begin sailing from Israel in May 02/22/21 Royal Caribbean sees net loss for Q1, FY21 02/22/21 Royal Caribbean sees FY21 CapEx $2.1B 02/22/21 Royal Caribbean: Monthly cash burn rate consistent with previously noted range PENN Penn National $115.83 / +0.02 (+0.02%) 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/23/21 Texas proposes constitutional amendment to legalize sports wagering 02/22/21 Rush Street Interactive enters strategic partnership with Penn National PBR Petrobras $7.92 / + (+0.00%) 02/22/21 Petrobras falls -22.0% 02/22/21 Petrobras falls -20.0% 02/22/21 Petrobras falls -21.3% 02/22/21 Petrobras says Ministry of Mines and Energy seeks meeting to replace CEO NRG NRG Energy $36.50 / + (+0.00%) 02/04/21 NRG Energy announces CFO Kirkland Andrews is stepping down 01/05/21 NRG Energy completes acquisition of Direct Energy 11/30/20 NRG Energy receives FERC approval for Direct Energy acquisition JNJ Johnson & Johnson $158.52 / +0.1 (+0.06%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA C Citi $65.86 / + (+0.00%) 02/25/21 Citi CFO says bank buying back shares in Q1 02/25/21 Citi CFO sees Q1 fixed income/equities trading revenue down mid-single-digits 02/24/21 Citi expands custody business in Nordics through referral agreement with Nordea BA Boeing $212.02 / + (+0.00%) 02/26/21 Bell-Boeing awarded $309.58M Navy contract modification 02/24/21 FAA: Pratt & Whitney engines must be inspected before flights resume 02/23/21 Spirit AeroSystems announces backlog of approximately $34B at end of Q4 02/23/21 Mesa Air signs LOI to lease additional 737-400F cargo aircraft RCL NRG JNJ PBR XOM RKT C BA WMT PENN RCL Royal Caribbean $93.43 / + (+0.00%) 02/24/21 Credit Suisse Royal Caribbean price target raised to $117 from $76 at Credit Suisse 02/23/21 JPMorgan Royal Caribbean price target raised to $100 from $91 at JPMorgan 02/23/21 Deutsche Bank Royal Caribbean price target raised to $79 from $62 at Deutsche Bank 02/12/21 Berenberg Royal Caribbean downgraded to Sell from Hold at Berenberg NRG NRG Energy $36.50 / + (+0.00%) 02/04/21 Fly Intel: Top five analyst initiations 02/04/21 Citi NRG Energy resumed with a Buy at Citi 01/28/21 Goldman Sachs NRG Energy reinstated with a Buy at Goldman Sachs 01/11/21 BofA BofA US 1 List changes JNJ Johnson & Johnson $158.52 / +0.1 (+0.06%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' PBR Petrobras $7.92 / + (+0.00%) 02/22/21 Fly Intel: Top five analyst downgrades 02/22/21 Scotiabank Scotiabank downgrades Petrobras on rising fuel price tension 02/22/21 BofA Petrobras double-downgraded to Underperform from Buy at BofA 02/22/21 BofA Petrobras downgraded to Underperform from Buy at BofA XOM Exxon Mobil $54.38 / + (+0.00%) 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas RKT Rocket Companies $21.84 / + (+0.00%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations C Citi $65.86 / + (+0.00%) 03/01/21 Wells Fargo Citi price target raised to $82 from $74 at Wells Fargo 01/21/21 Berenberg Berenberg downgrades Citi to Hold after 50% rally 01/21/21 Berenberg Citi downgraded to Hold from Buy at Berenberg 01/19/21 DA Davidson Citi price target raised to $84 from $77 at DA Davidson BA Boeing $212.02 / + (+0.00%) 03/01/21 Morgan Stanley Boeing price target raised to $250 from $230 at Morgan Stanley 02/19/21 Benchmark Boeing price target lowered to $270 from $290 at Benchmark 02/10/21 Deutsche Bank Airbus initiated with a Buy at Deutsche Bank 01/29/21 Fly Intel: Top five analyst upgrades Spire WMT Walmart $129.87 / -0.02 (-0.02%) 02/23/21 Evercore ISI Walmart accelerating change with investments, says Evercore ISI 02/19/21 Morgan Stanley Walmart terminal value rising with investments, says Morgan Stanley 02/19/21 Cowen Walmart weakness a buying opportunity, says Cowen 02/19/21 Deutsche Bank Walmart price target lowered to $166 from $170 at Deutsche Bank PENN Penn National $115.83 / +0.02 (+0.02%) 02/23/21 JPMorgan JPMorgan ups Penn National target, says don't wait for selloff to buy 02/22/21 Craig-Hallum Craig-Hallum reiterates $150 target on Penn National after Rush deal 02/09/21 Morgan Stanley Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds 02/05/21 Truist Penn National price target raised to $135 from $120 at Truist XOM WMT RKT RCL PENN NRG JNJ C BA XOM Exxon Mobil $54.38 / + (+0.00%) 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices WMT Walmart $129.87 / -0.02 (-0.02%) 02/18/21 Walmart reports Q4 adjusted EPS $1.39, consensus $1.51 02/17/21 Notable companies reporting before tomorrow's open 11/17/20 Walmart reports Q3 adjusted EPS $1.34, consensus $1.18 RKT Rocket Companies $21.84 / + (+0.00%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 RCL Royal Caribbean $93.43 / + (+0.00%) 02/22/21 Royal Caribbean reports Q4 adjusted EPS ($5.02), consensus ($5.20) 10/29/20 Royal Caribbean sees incurring loss for Q4 and FY20 10/29/20 Royal Caribbean reports Q3 adjusted EPS ($5.62), consensus ($5.12) 10/28/20 Notable companies reporting before tomorrow's open PENN Penn National $115.83 / +0.02 (+0.02%) 02/04/21 Penn National reports Q4 EPS 7c, consensus 24c 02/03/21 Notable companies reporting before tomorrow's open 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c NRG NRG Energy $36.50 / + (+0.00%) 03/01/21 NRG Energy reports Q4 revenue $2.21B, consensus $1.96B JNJ Johnson & Johnson $158.52 / +0.1 (+0.06%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open C Citi $65.86 / + (+0.00%) 01/15/21 Citi sees FY21 revenue down mid-to-high single digits, consensus $70.04B 01/15/21 Citi sees FY21 decline in net interest revenues $1B-$2B 01/15/21 Citi reports Q4 EPS $2.08, consensus $1.34 01/14/21 Notable companies reporting before tomorrow's open BA Boeing $212.02 / + (+0.00%) 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) 01 Mar 14 Oct 25 Sep 06 Aug 12 May XOM WMT RKT RCL PENN PBR JNJ C BA XOM Exxon Mobil $54.38 / + (+0.00%) 03/01/21 Ubben, Angelakis to join board of Exxon Mobil, CNBC reports 02/17/21 Texas prohibits natgas firms from taking fuel out of state, Bloomberg says 02/17/21 Saudis to raise oil output as prices recover, WSJ reports 02/05/21 Exxon considering nominating Jeff Ubben to board, CNBC reports WMT Walmart $129.87 / -0.02 (-0.02%) 03/01/21 Goldman's Omer Ismail leaving to run Walmart's fintech startup, WSJ reports 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 02/18/21 Walmart to raise wages for 425,000 store associates, Yahoo Finance reports 02/14/21 Walmart COVID vaccine rollout heading to small towns, WSJ reports RKT Rocket Companies $21.84 / + (+0.00%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports RCL Royal Caribbean $93.43 / + (+0.00%) 02/12/21 Royal Caribbean to require COVID-19 vaccinations for crew, Travel + Leisure says 12/08/20 Royal Caribbean cruise from Singapore return after suspected COVID case, ST says 11/13/20 Five people aboard SeaDream cruise ship test positive for COVID, CNN reports 09/30/20 White House planning meeting with cruise line CEOs for Friday, CNBC says PENN Penn National $115.83 / +0.02 (+0.02%) 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games PBR Petrobras $7.92 / + (+0.00%) 02/26/21 Petrobras CEO Roberto Castello Branco to step down on March 20, WSJ reports 02/24/21 Petrobras board agrees to meet to consider CEO change, WSJ reports 02/21/21 Future of Petrobas refinery sales in doubt, Reuters reports 02/19/21 Petrobras CEO resists pressure to resign, Reuters reports JNJ Johnson & Johnson $158.52 / +0.1 (+0.06%) 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports C Citi $65.86 / + (+0.00%) 02/27/21 Citigroup stock a Buy, Barron's says 02/19/21 Citi to consider divesting certain international consumer units, Bloomberg says 02/19/21 Citi to consider divesting certain international consumer units, Bloomberg says 02/19/21 Citi to consider divesting certain international consumer units, Bloomberg says BA Boeing $212.02 / + (+0.00%) 02/25/21 Boeing facing FAA fine, 'much bigger 787 repair bill,' Reuters says 02/25/21 Boeing facing FAA fine, 'much bigger 787 repair bill,' Reuters says 02/25/21 DOT: FAA must strengthen oversight of aircraft safety, WSJ reports 02/25/21 Boeing had planned to replace 777 engine covers before failures, WSJ reports XOM WMT RKT RCL PENN NRG JNJ C BA XOM Exxon Mobil $54.38 / + (+0.00%) 02/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/02/21 Fly Intel: Wall Street's top stories at midday 02/02/21 Fly Intel: Pre-market Movers WMT Walmart $129.87 / -0.02 (-0.02%) 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/18/21 Fly Intel: Wall Street's top stories at midday 02/18/21 Fly Intel: Pre-market Movers 02/17/21 Fly Intel: What to watch in Walmart's earnings report RKT Rocket Companies $21.84 / + (+0.00%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers RCL Royal Caribbean $93.43 / + (+0.00%) 12/03/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/09/20 Fly Intel: Pre-market Movers PENN Penn National $115.83 / +0.02 (+0.02%) 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting 02/05/21 Bet On It: Georgia online sports betting bill passes first test NRG NRG Energy $36.50 / + (+0.00%) 03/01/21 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $158.52 / +0.1 (+0.06%) 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday C Citi $65.86 / + (+0.00%) 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Fly Intel: Wall Street's top stories at midday 01/15/21 The Intersection: Crypto and Wall Street This Week 11/18/20 Fly Intel: Wall Street's top stories for Wednesday BA Boeing $212.02 / + (+0.00%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers 01/29/21 Boeing double upgrade among today's top calls on Wall Street 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 03/01/21 26th Annual Energy Virtual Summit 00:00 Today 41st Annual Healthcare Virtual Conference 03/01/21 NRG Energy - NRG 04/15/21 Citi - C 04/20/21 Johnson & Johnson - JNJ 03/03/21 Exxon Mobil Corp. 04/20/21 Boeing Co. XOM WMT RKT RCL PENN PBR NRG JNJ C BA XOM Exxon Mobil $54.38 / + (+0.00%) 02/09/21 Unusually active option classes on open February 9th 02/08/21 Exxon Mobil call volume above normal and directionally bullish 02/08/21 Unusually active option classes on open February 8th 02/05/21 Exxon Mobil call volume above normal and directionally bullish WMT Walmart $129.87 / -0.02 (-0.02%) 02/18/21 Unusually active option classes on open February 18th 11/17/20 Unusually active option classes on open November 17th 09/02/20 Notable open interest changes for September 2nd 09/02/20 Wal-Mart call buyer realizes 124% same-day gains RKT Rocket Companies $21.84 / + (+0.00%) 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings 02/19/21 Largest borrow rate increases among liquid names 02/18/21 Largest borrow rate increases among liquid names 02/03/21 Rocket Companies call volume above normal and directionally bullish RCL Royal Caribbean $93.43 / + (+0.00%) 02/16/21 Royal Caribbean call volume above normal and directionally bullish 02/16/21 Early notable gainers among liquid option names on February 16th 12/31/20 Unusually active option classes on open December 31st 12/30/20 Royal Caribbean call volume above normal and directionally bullish PENN Penn National $115.83 / +0.02 (+0.02%) 01/12/21 Penn National call volume above normal and directionally bullish 12/16/20 Penn National call volume above normal and directionally bullish 12/14/20 Penn National call volume above normal and directionally bullish 12/08/20 Penn National call volume above normal and directionally bullish PBR Petrobras $7.92 / + (+0.00%) 02/25/21 Notable open interest changes for February 25th 02/24/21 Unusually active option classes on open February 24th 02/23/21 Notable open interest changes for February 23rd 02/18/21 Petrobras put volume heavy and directionally bearish NRG NRG Energy $36.50 / + (+0.00%) 02/26/21 NRG Energy put volume heavy and directionally bearish JNJ Johnson & Johnson $158.52 / +0.1 (+0.06%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd C Citi $65.86 / + (+0.00%) 12/11/20 Citi put volume heavy and directionally bearish 11/09/20 Citi call volume above normal and directionally bullish 10/26/20 Citi call volume above normal and directionally bullish 10/14/20 Notable open interest changes for October 14th BA Boeing $212.02 / + (+0.00%) 02/24/21 Boeing call volume above normal and directionally bullish 02/16/21 Boeing call volume above normal and directionally bullish 01/29/21 Boeing call volume above normal and directionally bullish 12/07/20 Early notable gainers among liquid option names on December 7th
On The Fly	Fly Intel: Pre-market Movers » 09:15 03/01/21 03/01 09:15 03/01/21 09:15 JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) , XOM Exxon Mobil $54.38 / -1.37 (-2.46%) , XRAY Dentsply Sirona $53.11 / +0.64 (+1.22%) , PRGO Perrigo $40.20 / -0.58 (-1.42%) , NRG NRG Energy $36.50 / -1.06 (-2.82%) , SSYS Stratasys $34.48 / +0.29 (+0.85%) , LOGI Logitech $108.00 / +2.23 (+2.11%) , ATNX Athenex $12.18 / +0.29 (+2.44%) , CEO Cnooc $118.84 / -8.41 (-6.61%) , VACQ Vector Acquisition $10.27 / -0.01 (-0.10%) Check out this morning's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XRAY XOM VACQ SSYS PRGO NRG LOGI JNJ CEO ATNX XRAY Dentsply Sirona $53.11 / +0.64 (+1.22%) 01/04/21 Dentsply Sirona acquires Byte in $1.04B all-cash deal 01/04/21 Dentsply Sirona acquires Byte in $1.04B all cash deal XOM Exxon Mobil $54.38 / -1.37 (-2.46%) 03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 02/12/21 Exxon Mobil targets cash operating expense reduction of $6B by FY23 VACQ Vector Acquisition $10.27 / -0.01 (-0.10%) 03/01/21 Rocket Lab USA , Vector Acquisition announce merger pact SSYS Stratasys $34.48 / +0.29 (+0.85%) 03/01/21 Stratasys expects Q1 revenue to track similarly to 1Q20 02/18/21 Stratasys acquires U.K.-based RP Support Ltd., terms not stated 02/18/21 Stratasys acquires RPS, provider of best-in-class' stereolithography 3D printers 12/09/20 Stratasys to acquire Origin for total consideration of up to $100M PRGO Perrigo $40.20 / -0.58 (-1.42%) 03/01/21 Perrigo to sell Generic Rx business to Altaris Capital Partners for $1.55B 02/23/21 Perrigo increases quarterly dividend 7% 01/11/21 Perrigo, Michigan State University announce partnership 11/04/20 Perrigo plans to purchase $150M of common stock by end of 2020 NRG NRG Energy $36.50 / -1.06 (-2.82%) 02/04/21 NRG Energy announces CFO Kirkland Andrews is stepping down 01/05/21 NRG Energy completes acquisition of Direct Energy 11/30/20 NRG Energy receives FERC approval for Direct Energy acquisition LOGI Logitech $108.00 / +2.23 (+2.11%) 01/19/21 Logitech CEO: We're going to be right in the center of how people work 01/18/21 Logitech does not expect level of margin expansion to sustain 11/15/20 Fly Intel: Top five weekend stock stories 10/20/20 Logitech CEO: It was a great quarter JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA CEO Cnooc $118.84 / -8.41 (-6.61%) 03/01/21 NYSE to delist Cnooc American depositary shares 02/22/21 Cnooc announces oil discovery Bozhong 13-2 in Bohai Bay 02/04/21 Cnooc sees FY21 production 545M-555M BOE 12/14/20 Cnooc announces Penglai 25-6 oilfield area 3 project commences ahead of schedule ATNX Athenex $12.18 / +0.29 (+2.44%) 03/01/21 Athenex trading resumes 03/01/21 Athenex expects cash to fund operations into 2Q22 03/01/21 Athenex announces key anticipated future milestones 03/01/21 FDA requests new study from Athenex for oral paclitaxel plus encequidar JNJ XOM XRAY PRGO NRG SSYS LOGI ATNX CEO VACQ JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' XOM Exxon Mobil $54.38 / -1.37 (-2.46%) 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays 02/16/21 Credit Suisse Exxon Mobil price target raised to $62 from $52 at Credit Suisse 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Exane BNP Paribas Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas XRAY Dentsply Sirona $53.11 / +0.64 (+1.22%) 02/09/21 Stifel Dentsply Sirona checks point to potential channel conflict, says Stifel 01/08/21 Credit Suisse Envista upgraded to Outperform from Neutral at Credit Suisse 01/05/21 Baird Dentsply Sirona price target raised to $62 from $58 at Baird 01/05/21 Barclays Dentsply Sirona price target raised to $44 from $40 at Barclays PRGO Perrigo $40.20 / -0.58 (-1.42%) 01/06/21 RBC Capital Perrigo downgraded to Sector Perform from Outperform at RBC Capital 01/06/21 RBC Capital Perrigo downgraded to Sector Perform from Outperform at RBC Capital 10/19/20 Morgan Stanley Morgan Stanley sees volatility in Perrigo on Irish tax litigation ruling 06/16/20 JPMorgan Perrigo tax dispute well reflected in shares, says JPMorgan NRG NRG Energy $36.50 / -1.06 (-2.82%) 02/04/21 Fly Intel: Top five analyst initiations 02/04/21 Citi NRG Energy resumed with a Buy at Citi 01/28/21 Goldman Sachs NRG Energy reinstated with a Buy at Goldman Sachs 01/11/21 BofA BofA US 1 List changes SSYS Stratasys $34.48 / +0.29 (+0.85%) 01/19/21 Stifel Stratasys initiated with a Buy at Stifel 01/15/21 JPMorgan Stratasys downgraded to Underweight from Neutral at JPMorgan 10/09/20 Berenberg Stratasys initiated with a Buy at Berenberg 09/24/20 Fly Intel: Top five analyst downgrades LOGI Logitech $108.00 / +2.23 (+2.11%) 02/22/21 UBS Logitech price target raised to CHF 108 from CHF 90 at UBS 02/10/21 DA Davidson Corsair Gaming price target raised to $52 from $33 at DA Davidson 01/21/21 UBS Logitech price target raised to CHF 90 from CHF 74 at UBS 01/20/21 Citi Logitech price target raised to $130 from $110 at Citi ATNX Athenex $12.18 / +0.29 (+2.44%) 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Evercore ISI Athenex initiated with an Outperform at Evercore ISI 10/26/20 Fly Intel: Top five analyst initiations 10/26/20 SVB Leerink Athenex initiated with an Outperform at SVB Leerink CEO Cnooc $118.84 / -8.41 (-6.61%) 01/04/21 Bernstein Cnooc upgraded to Outperform from Market Perform at Bernstein 12/01/20 Bernstein Cnooc downgraded to Market Perform from Outperform at Bernstein 11/22/20 Goldman Sachs Cnooc initiated with a Buy at Goldman Sachs 08/19/20 Credit Suisse Cnooc upgraded to Outperform from Underperform at Credit Suisse VACQ Vector Acquisition $10.27 / -0.01 (-0.10%) XRAY XOM SSYS PRGO NRG LOGI JNJ ATNX XRAY Dentsply Sirona $53.11 / +0.64 (+1.22%) 03/01/21 Dentsply Sirona sees FY21 adjusted EPS $2.60-$2.80, consensus $2.39 03/01/21 Dentsply Sirona reports Q4 adjusted EPS 87c, consensus 64c 11/05/20 Dentsply Sirona reports Q3 non-GAAP EPS 67c, consensus 32c 11/04/20 Notable companies reporting before tomorrow's open XOM Exxon Mobil $54.38 / -1.37 (-2.46%) 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices SSYS Stratasys $34.48 / +0.29 (+0.85%) 03/01/21 Stratasys reports Q4 EPS 13c, consensus 0c 11/12/20 Stratasys reports Q3 non-GAAP EPS (5c), consensus (7c) PRGO Perrigo $40.20 / -0.58 (-1.42%) 03/01/21 Perrigo sees FY21 Worldwide Consumer organic net sales growth of 3% 03/01/21 Perrigo reports Q4 adjusted EPS 93c, consensus $1.00 11/04/20 Perrigo backs FY20 net sales growth of 6%-7%, consensus $5.14B 11/04/20 Perrigo backs FY20 adjusted EPS view $3.95-$4.15, consensus $4.06 NRG NRG Energy $36.50 / -1.06 (-2.82%) 03/01/21 NRG Energy reports Q4 revenue $2.21B, consensus $1.96B LOGI Logitech $108.00 / +2.23 (+2.11%) 03/01/21 Logitech sees FY22 revenue flat +/- 5%, consensus $4.47B 03/01/21 Logitech raises FY21 revenue view to up 63% from up 57%-60%, consensus $4.8B 01/18/21 Logitech raises FY21 sales growth outlook to 57%-60% from 35%-40% 01/18/21 Logitech reports Q3 EPS $2.45, consensus $1.02 JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open ATNX Athenex $12.18 / +0.29 (+2.44%) 03/01/21 Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c) 10 Sep XOM VACQ LOGI JNJ XOM Exxon Mobil $54.38 / -1.37 (-2.46%) 03/01/21 Ubben, Angelakis to join board of Exxon Mobil, CNBC reports 02/17/21 Texas prohibits natgas firms from taking fuel out of state, Bloomberg says 02/17/21 Saudis to raise oil output as prices recover, WSJ reports 02/05/21 Exxon considering nominating Jeff Ubben to board, CNBC reports VACQ Vector Acquisition $10.27 / -0.01 (-0.10%) 02/28/21 Vector Acquisition near deal to take Rocket Lab USA public, WSJ reports LOGI Logitech $108.00 / +2.23 (+2.11%) 11/14/20 Logitech business already booming before COVID, Barron's says 10/05/20 Apple ceases sale of rival earphones, speakers, Bloomberg reports 10/05/20 Apple ceases sale of rival earphones, speakers, Bloomberg reports 09/26/20 TVs getting left behind as videoconferencing booms, Barron's says JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports XRAY XOM VACQ PRGO LOGI JNJ ATNX XRAY Dentsply Sirona $53.11 / +0.64 (+1.22%) 11/05/20 Fly Intel: Pre-market Movers XOM Exxon Mobil $54.38 / -1.37 (-2.46%) 02/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/02/21 Fly Intel: Wall Street's top stories at midday 02/02/21 Fly Intel: Pre-market Movers 02/01/21 Fly Intel: Wall Street's top stories for Monday VACQ Vector Acquisition $10.27 / -0.01 (-0.10%) 09/27/20 Opening Day: GoodRx rises over 50% in market debut PRGO Perrigo $40.20 / -0.58 (-1.42%) 11/04/20 Fly Intel: After-Hours Movers 09/24/20 Rising High: An exclusive talk with large-scale CBD producer Kazmira 09/17/20 Fly Intel: Pre-market Movers LOGI Logitech $108.00 / +2.23 (+2.11%) 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/06/20 Fly Intel: Wall Street's top stories for Tuesday 10/06/20 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday ATNX Athenex $12.18 / +0.29 (+2.44%) 12/15/20 Fly Intel: Pre-market Movers 09/21/20 Fly Insider: Kingsway Financial, Nvidia among week's notable insider trades 09/10/20 Fly Intel: Pre-market Movers 09/08/20 Fly Intel: After-Hours Movers 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 03/01/21 26th Annual Energy Virtual Summit 00:00 Today 41st Annual Healthcare Virtual Conference 03/01/21 Perrigo - PRGO 03/01/21 Athenex - ATNX 03/01/21 Dentsply Sirona - XRAY 03/01/21 Stratasys - SSYS 03/01/21 NRG Energy - NRG 04/20/21 Johnson & Johnson - JNJ 03/01/21 Logitech 03/03/21 Exxon Mobil Corp. XRAY XOM SSYS NRG LOGI JNJ XRAY Dentsply Sirona $53.11 / +0.64 (+1.22%) 10/22/20 Early notable gainers among liquid option names on October 22nd XOM Exxon Mobil $54.38 / -1.37 (-2.46%) 02/09/21 Unusually active option classes on open February 9th 02/08/21 Exxon Mobil call volume above normal and directionally bullish 02/08/21 Unusually active option classes on open February 8th 02/05/21 Exxon Mobil call volume above normal and directionally bullish SSYS Stratasys $34.48 / +0.29 (+0.85%) 02/25/21 Stratasys call volume above normal and directionally bullish 01/07/21 Stratasys call volume above normal and directionally bullish 12/17/20 Stratasys call volume above normal and directionally bullish NRG NRG Energy $36.50 / -1.06 (-2.82%) 02/26/21 NRG Energy put volume heavy and directionally bearish LOGI Logitech $108.00 / +2.23 (+2.11%) 01/05/21 Largest borrow rate increases among liquid names 12/24/20 Largest borrow rate increases among liquid names 11/09/20 Logitech put volume heavy and directionally bearish 10/28/20 Logitech put volume heavy and directionally bearish JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd

On The Fly

News and insights, exclusive to thefly.com

20:25	Notable companies reporting before tomorrow's open»
16:38	JPMorgan downgrades Athenex on 'huge surprise' from FDA»
13:49	Notable companies reporting before tomorrow's open»
13:47	Notable companies reporting after market close»
12:48	Morphic Holding price target raised to $103 from $40 at Wells Fargo»

View all On The Fly Stories »

Upcoming
Events (10)

Today	KMPH	PDUFA Date for KP415
Today	AOSL	Alpha & Omega - AOSL
Today	UEPS	Net 1 UEPS - UEPS
Today		Global Emerging Markets Corporate Virtual Conference
Today		ESMO TAT Virtual Congress 2021
Today		30th Global Metals & Mining Virtual Conference
Today		Advances in Genome Biology & Technology: AGBT 2021 Virtual Event
Today		Global High Yield & Leveraged Finance Virtual Conference
Today		Microsoft Ignite
Today		Western Financial Services Virtual Conference

View all of today’s events »

Today’s
Syndicate (9)

SWTX	Block Trade
KRTX	Secondary
EAF	Spot Secondary
FRC	Spot Secondary
HLNE	Spot Secondary
JELD	Spot Secondary
RDHL	Spot Secondary
SITC	Spot Secondary
WSC	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial